Add Company
Join Now

Biolumic Revenue and Competitors

License our Company Data API

Palmerston North,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Biolumic's estimated annual revenue is currently $6.4M per year.(i)
  • Biolumic's estimated revenue per employee is $155,000

Employee Data

  • Biolumic has 41 Employees.(i)
  • Biolumic grew their employee count by -5% last year.

Biolumic's People

NameTitleEmail/Phone
1
R&D ScientistReveal Email/Phone
2
Lead Operations EngineerReveal Email/Phone
3
Senior AgronomistReveal Email/Phone
4
Research And Development ScientistReveal Email/Phone
5
Research And Development ScientistReveal Email/Phone
6
Senior ScientistReveal Email/Phone
7
Design & Content LeadReveal Email/Phone
8
R&D ScientistReveal Email/Phone
9
R&D ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Biolumic?

BioLumic develops and deploys light signals that unlock the natural genetic potential of seeds and seedlings—without requiring use of chemicals or genetic modification. BIoLumic's technology triggers biological mechanisms that have demonstrated increases in plant yield, vigor, and disease resistance. In soybean seeds, our light signals are producing traits and yield benefits that stack onto other treatments without any additional material. In cannabis, we have produced 40%+ increases in THC concentration and 30%+ increases in dry weight yield with advantageous composition improvements.

keywords:N/A

N/A

Total Funding

41

Number of Employees

$6.4M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.1M4330%N/A
#2
$14.6M6025%N/A
#3
$42.6M10022%N/A
#4
$31.6M1098%N/A
#5
$15M2636%N/A